Healthequity Stock Insiders

HQY -  USA Stock  

USD 62.80  1.82  2.98%

Healthequity employes about 3.7 K people. The company is managed by 25 executives with total tenure of roughly 175 years, averaging almost 7.0 years of service per executive having 147.52 employees per reported executive. Break down of Healthequity management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Healthequity future performance.
Please check Risk vs Return Analysis.
  
Refresh
  Jon Kessler  CEO
CEO and President and Director
  Robert Selander  Chairman
Non-Executive Chairman of the Board
  Stephen Neeleman  Chairman
Vice Chairman of the Board, Founder

Healthequity Return on Sales

(0.0411)

Share

Healthequity Management Team Effectiveness

Healthequity has Return on Asset of 0.87 % which means that on every $100 spent on asset, it made $0.87 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (2.74) %, meaning that it generated no profit with money invested by stockholders. Healthequity management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to rise to 1.74 in 2022, whereas Return on Average Assets are likely to drop (0.0144)  in 2022. Healthequity Total Assets are fairly stable at the moment as compared to the past year. Healthequity reported Total Assets of 3.11 Billion in 2021. Assets Non Current is likely to rise to about 3 B in 2022, whereas Current Assets are likely to drop slightly above 316.7 M in 2022.

Healthequity Quarterly Total Assets

3.11 Billion

Share
Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Weighted Average Shares is likely to drop slightly above 72.9 M in 2022.

Healthequity Workforce Comparison

Healthequity is rated # 2 in number of employees category among related companies. The total workforce of Health Information Services industry is currently estimated at about 36,974. Healthequity holds roughly 3,688 in number of employees claiming about 10% of equities under Health Information Services industry.

Healthequity Profit Margins

The company has Net Profit Margin of (5.85) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 5.36 %, which entails that for every 100 dollars of revenue, it generated 0.05 of operating income.

Healthequity Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Healthequity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Healthequity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Healthequity insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Healthequity Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Healthequity Price Series Subtraction is a subtraction of Healthequity price series from its benchmark/peer..
.

Healthequity Notable Stakeholders

A Healthequity stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Healthequity often face trade-offs trying to please all of them. Healthequity's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Healthequity's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jon Kessler - CEO and President and DirectorProfile
Robert Selander - Non-Executive Chairman of the BoardProfile
Stephen Neeleman - Vice Chairman of the Board, FounderProfile
Frode Jensen - Executive Vice President - General council and secreteryProfile
Edward Bloomberg - COO, Executive Vice PresidentProfile
William Otten - Executive Vice President of SalesProfile
Larry Trittschuh - Executive Vice President Chief Security OfficerProfile
Delano Ladd - Executive Vice President General Counsel and Corporate SecretaryProfile
Gary Robinson - Executive Vice President Chief Marketing OfficerProfile
Angelique Hill - Executive Vice President - OperationsProfile
Jonathan Soldan - Executive Vice President - OperationsProfile
Ashley Dreier - Executive Vice President CTO and CIOProfile
Darcy Mott - CFO, Executive VP and TreasurerProfile
Matthew Sydney - Executive VP of Sales and MarketingProfile
Jon Soldan - Executive VP of OperationsProfile
Evelyn Dilsaver - Independent DirectorProfile
Adrian Dillon - DirectorProfile
Debra McCowan - DirectorProfile
Frank Corvino - Independent DirectorProfile
Manu Rana - Independent DirectorProfile
Ian Sacks - Independent DirectorProfile
Michael Leavitt - Independent DirectorProfile
Gayle Wellborn - DirectorProfile
Frank Medici - Independent DirectorProfile
Richard Putnam - IR Contact OfficerProfile

About Healthequity Management Performance

The success or failure of an entity such as Healthequity often depends on how effective the management is. Healthequity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Healthequity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Healthequity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Return on Investment 1.69  1.74 
Return on Average Assets(0.014) (0.0144) 
Return on Average Equity(0.024) (0.0246) 
Return on Invested Capital(0.026) (0.0267) 
Return on Sales(0.04) (0.0411) 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.
The data published in Healthequity's official financial statements usually reflect Healthequity's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Healthequity. For example, before you start analyzing numbers published by Healthequity accountants, it's critical to develop an understanding of what Healthequity's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Healthequity's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Healthequity's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Healthequity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Healthequity. Please utilize our Beneish M Score to check the likelihood of Healthequity's management to manipulate its earnings.

Healthequity Workforce Analysis

Traditionally, organizations such as Healthequity use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Healthequity within its industry.

Healthequity Manpower Efficiency

Return on Healthequity Manpower

Revenue Per Employee201.2 K
Revenue Per Executive30.3 M
Net Income Per Employee2.7 K
Net Loss Per Executive1.8 M
Working Capital Per Employee35.5 K
Working Capital Per Executive5.2 M
Today, most investors in Healthequity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Healthequity's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's per employee growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Healthequity per employee as a starting point in their analysis.

Per Employee

Healthequity Per Employee Growth Over Time

Net Income Per Employee

2,677.76

Share
Healthequity Net Income Per Employee is fairly stable at the moment as compared to the past year. Healthequity reported Net Income Per Employee of 2,609 in 2021

Revenue Per Employee

201,184

Share
Healthequity Revenue Per Employee is fairly stable at the moment as compared to the past year. Healthequity reported Revenue Per Employee of 216,653 in 2021
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.